RhumbLine Advisers’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

RhumbLine Advisers’s Portfolio TCBP Stock Details TCBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5	Closed	-$1	–	4192
2025 Q3	$1	Sell	5 -183	-97%	-$37	﹤0.01%	4116
2025 Q2	$38	Sell	188 -46	-20%	-$9	﹤0.01%	4120
2025 Q1	$46	Buy	234 +161	+221%	+$715	﹤0.01%	4106
2024 Q4	$749	Buy	73 +68	+1,360%	+$2.1K	﹤0.01%	4086
2024 Q3	$439	Hold	5	–	–	﹤0.01%	4127
2024 Q2	$691	Buy	+5	New	+$1K	﹤0.01%	4270

RhumbLine Advisers's TCBP Position: Q4 2025 in Review

RhumbLine Advisers sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q4 2025, closing a stake of 5 shares — an estimated $1 sold.

RhumbLine Advisers first reported a position in TCBP in Q2 2024 and held it in 6 quarters. The position peaked at $749 in Q4 2024. 0 funds tracked by Wall St. Rank hold TCBP as of Q4 2025.

RhumbLine Advisers reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q4 2025 after selling out during the quarter.
RhumbLine Advisers sold 5 TC BioPharm (Holdings) plc American Depositary Shares shares in Q4 2025, an estimated $1.
RhumbLine Advisers first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q2 2024 and held it in 6 quarters.
RhumbLine Advisers's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $749 in Q4 2024.
0 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q4 2025.

Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.